Recent Finacing
Recent Raise
iXCells Biotechnologies provides disease-relevant primary and iPSC-derived cells, custom iPSC services, functional bioassay development, and drug screening for academic, biotech, and pharmaceutical preclinical research.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at iXCells Biotechnologies.
